FNY Investment Advisers’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,000
Closed -$29K 1063
2018
Q3
$29K Buy
+3,000
New +$29K 0.01% 398